BIOTEST AG

In News

BIO.DE Biotest AG on XETRA pre-market: €42.20 shows oversold bounce opportunity - Meyka

Meyka - Jan 24, 2026

Grifols’ Biotest wins first regulatory approval for its fibrinogen concentrate - The Pharma Letter

The Pharma Letter - Nov 13, 2025

Ashurst advises Biotest on the public delisting offer by GRIFOLS and its delisting from the Frankfurt Stock Exchange - Ashurst

Ashurst - Jun 12, 2025

Osborne Clarke advises Grifols on delisting offer and delisting from stock exchange of Biotest - Osborne Clarke

Osborne Clarke - Jun 16, 2025

Swarm Oncology appoints Bernhard Ehmer as Chairman - The Manila Times

The Manila Times - Mar 05, 2026

Grifols’ Biotest to launch Yimmugo in USA - The Pharma Letter

The Pharma Letter - Oct 10, 2025

Kedrion and Biotest complete long-term Exclusive Distribution Agreement for Yimmugo® in the US - PR Newswire

PR Newswire - Oct 02, 2024

Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors - Business Wire

Business Wire - Nov 08, 2024

Grifols agrees to acquire Tiancheng Pharmaceutical for $1.3bn - Pharmaceutical Technology

Pharmaceutical Technology - Sep 20, 2021

IgM-enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices - Wiley Online Library

Wiley Online Library - Jul 19, 2022

Grifols Buys Biotest as Creat Pushed to Exit Blood-Plasma Stakes - Bloomberg.com

Bloomberg.com - Sep 17, 2021

FDA Approves the Intravenous Immunoglobulin G Yimmugo to Treat Primary Immunodeficiencies - Pharmacy Times

Pharmacy Times - Jun 17, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment